BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loftsson T. Cyclodextrins in Parenteral Formulations. J Pharm Sci 2021;110:654-64. [PMID: 33069709 DOI: 10.1016/j.xphs.2020.10.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Paiva-santos AC, Ferreira L, Peixoto D, Silva F, Soares MJ, Zeinali M, Zafar H, Mascarenhas-melo F, Raza F, Mazzola PG, Veiga F. Cyclodextrins as an encapsulation molecular strategy for volatile organic compounds – pharmaceutical applications. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Topuz F, Uyar T. Advances in the development of cyclodextrin-based nanogels/microgels for biomedical applications: Drug delivery and beyond. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.120033] [Reference Citation Analysis]
3 de Freitas Domingues JS, Dos Santos SMD, das Neves Rodrigues Ferreira J, Monti BM, Baggio DF, Hummig W, Araya EI, de Paula E, Chichorro JG, Ferreira LEN. Antinociceptive effects of bupivacaine and its sulfobutylether-β-cyclodextrin inclusion complex in orofacial pain. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35909169 DOI: 10.1007/s00210-022-02278-4] [Reference Citation Analysis]
4 Ferreira L, Campos J, Veiga F, Cardoso C, Cláudia Paiva-Santos A. Cyclodextrin-based delivery systems in parenteral formulations: a critical update review. Eur J Pharm Biopharm 2022:S0939-6411(22)00145-X. [PMID: 35868490 DOI: 10.1016/j.ejpb.2022.07.007] [Reference Citation Analysis]
5 Li T, Guo R, Zong Q, Ling G. Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin. Carbohydr Polym 2022;276:118644. [PMID: 34823758 DOI: 10.1016/j.carbpol.2021.118644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
6 Prajapati M, Loftsson T. Stabilization and solubilization of difluprednate in aqueous cyclodextrin solution and its characterization for ophthalmic delivery. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Poulson BG, Alsulami QA, Sharfalddin A, El Agammy EF, Mouffouk F, Emwas A, Jaremko L, Jaremko M. Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications. Polysaccharides 2022;3:1-31. [DOI: 10.3390/polysaccharides3010001] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Martín Bellido V, Vettorato E. Clinical review of the pharmacological and anaesthetic effects of alfaxalone in dogs. J Small Anim Pract 2021. [PMID: 34893985 DOI: 10.1111/jsap.13454] [Reference Citation Analysis]
9 Piñeiro Á, Pipkin J, Antle V, Garcia-Fandino R. Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir. J Mol Liq 2021;343:117588. [PMID: 34548723 DOI: 10.1016/j.molliq.2021.117588] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Bouattour Y, Neflot-Bissuel F, Traïkia M, Biesse-Martin AS, Frederic R, Yessaad M, Jouannet M, Wasiak M, Chennell P, Sautou V. Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis. Int J Mol Sci 2021;22:10538. [PMID: 34638878 DOI: 10.3390/ijms221910538] [Reference Citation Analysis]
11 Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs 2021;81:1513-57. [PMID: 34480749 DOI: 10.1007/s40265-021-01579-x] [Reference Citation Analysis]
12 Rejinold NS, Piao H, Jin GW, Choi G, Choy JH. Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy. Colloids Surf B Biointerfaces 2021;208:112063. [PMID: 34482191 DOI: 10.1016/j.colsurfb.2021.112063] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Rincón-López J, Almanza-Arjona YC, Riascos AP, Rojas-Aguirre Y. When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications through Network Science and Text-Mining. Pharmaceutics 2021;13:1297. [PMID: 34452258 DOI: 10.3390/pharmaceutics13081297] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Jug M, Yoon BK, Jackman JA. Cyclodextrin-based Pickering emulsions: functional properties and drug delivery applications. J Incl Phenom Macrocycl Chem 2021;:1-20. [PMID: 34366706 DOI: 10.1007/s10847-021-01097-z] [Reference Citation Analysis]
15 Rassu G, Sorrenti M, Catenacci L, Pavan B, Ferraro L, Gavini E, Bonferoni MC, Giunchedi P, Dalpiaz A. Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives? Pharmaceutics 2021;13:1180. [PMID: 34452141 DOI: 10.3390/pharmaceutics13081180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shah AA, Shah A, Lewis S, Ghate V, Saklani R, Narayana Kalkura S, Baby C, Singh PK, Nayak Y, Chourasia MK. Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis. Eur J Pharm Biopharm 2021;167:127-39. [PMID: 34329710 DOI: 10.1016/j.ejpb.2021.07.008] [Reference Citation Analysis]
17 Szabó ZI, Orbán G, Borbás E, Csicsák D, Kádár S, Fiser B, Dobó M, Horváth P, Kiss E, Budai L, Dobos J, Pálla T, Őrfi L, Völgyi G, Tóth G. Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility. Heliyon 2021;7:e07581. [PMID: 34355087 DOI: 10.1016/j.heliyon.2021.e07581] [Reference Citation Analysis]
18 Jicsinszky L, Martina K, Cravotto G. Cyclodextrins in the antiviral therapy. J Drug Deliv Sci Technol 2021;64:102589. [PMID: 34035845 DOI: 10.1016/j.jddst.2021.102589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Jødal AS, Czaja TP, van den Berg FWJ, Jespersen BM, Larsen KL. The Effect of α-, β- and γ-Cyclodextrin on Wheat Dough and Bread Properties. Molecules 2021;26:2242. [PMID: 33924497 DOI: 10.3390/molecules26082242] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Prajapati M, Christensen G, Paquet-Durand F, Loftsson T. Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations. Molecules 2021;26:1492. [PMID: 33803405 DOI: 10.3390/molecules26051492] [Cited by in F6Publishing: 3] [Reference Citation Analysis]